INSIGHTS ON REGULATORY COMPLIANCE
-
Perspectives On Performance, Scalability, And Regulatory Compliance
Here, we discuss the challenges and solutions for cell and gene therapies, focusing on performance, scalability, and regulatory compliance to accelerate commercialization and improve patient access.
-
5 Signs You've Outgrown Your Quality Management System (QMS)
An outdated QMS limits growth. Explore how upgrading to an advanced, configurable system like MasterControl can ensure scalability, automation and innovation.
-
How To Overcome Common Single-Use Assembly Design Challenges
Single-use systems offer major benefits in pharma manufacturing, but design complexity brings challenges. Learn how to overcome issues like scalability and quality assurance with integrated strategies.
-
Unlocking Digital Transformation: Embrace CSA For Rapid Innovation
Gain valuable insights from industry leaders on how life sciences manufacturers can embrace innovation and digital transformation through the FDA’s CSA guidance.
-
A Supplier-Manufacturer Approach To Mitigating Nitrosamine Risk10/10/2024
Learn about how nitrosamines are formed, their prevalence and chemical precursors in pharmaceuticals, techniques for quantification, and approaches for managing nitrite impurities.
-
5 Trends Impacting CMOs In 20252/4/2025
In 2025, CMOs will navigate Annex 1 compliance, the BioSecure Act’s uncertainty, AI-driven drug development, supply chain challenges from tariffs, and pandemic preparedness strategies.
-
Getting Equipped For The Future With A New Microbial Air Sampler8/25/2025
Discover how a new microbial air sampler meets evolving production demands to enhance compliance, reduce errors, and streamline air monitoring in today’s digital, GMP-regulated environment.
-
Resolute® BioSC Pilot: Designed For Effective And Consistent Chemical And Microbiological Cleaning10/10/2024
Issues related to cleaning and cleaning validation are some of the most common concerns that arise in FDA Warning Letters. Discover how to ensure you pass your cleaning validation tests.
-
Software Simplifies 21 CFR Part 11 and Annex 11 Compliance12/9/2024
21 CFR Part 11 and Annex 11 regulate electronic records and signatures in biomanufacturing, ensuring data integrity, security, and compliance while enabling efficient processes and regulatory alignment.
REGULATORY COMPLIANCE SOLUTIONS
-
Explore a line of cost-effective and flexible thermogravimetric analyzers that provides enhancements in every aspect of TGA technology and a new level of user experience.
-
Explore the technicalities of the M-Trace™ Electronic Test Record Software, a solution that automizes and digitalizes all data recording steps during sterility testing and other quality control workflows.
-
Become compliant with FDA 21 CFR Part 11 and EudraLex Annex 11 software validation
SoftMax® Pro 7.2 GxP Software is the latest, most secure software to achieve full FDA 21 CFR Part 11 and EudraLex Annex 11 compliance with streamlined workflows to ensure data integrity. Every step is optimized to simplify analysis and reporting to support our microplate readers.
-
Automate research and clinical workflows with intuitive setup, fewer errors, and optimized instrument use that supports regulated environments and delivers personalized service.
-
Explore a line of validation products and services addressing different levels of validation needs based on individual risk assessment. They're designed to allow “continuous validation” for FDA-regulated companies.